A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous Pregabalin and Acetaminophen (Ofirmev) in Healthy Volunteers
Latest Information Update: 06 Aug 2020
At a glance
- Drugs Paracetamol (Primary) ; Pregabalin (Primary)
- Indications Postoperative pain
- Focus Adverse reactions
- Sponsors Nevakar
Most Recent Events
- 04 Aug 2020 Status changed from recruiting to completed.
- 13 Feb 2020 New trial record